Androgen deprivation therapy: evidence‐based management of side effects

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

2009 • 1,070 citations

Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial

2009 • 609 citations

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

2011 • 410 citations

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

2010 • 357 citations

Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention

2009 • 198 citations

Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials

2011 • 194 citations

Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life

2010 • 138 citations

Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial

2009 • 130 citations

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

2011 • 124 citations

Determinants of Androgen Deprivation Therapy Use for Prostate Cancer: Role of the Urologist

2006 • 124 citations

Management of complications of androgen deprivation therapy in the older man

2008 • 75 citations

Hematological changes during androgen deprivation therapy

2012 • 56 citations

Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial.

2012 • 50 citations

Acupuncture for treating hot flushes in men with prostate cancer: a systematic review

2009 • 42 citations

Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

2011 • 40 citations

Established leukemia cell lines: Their role in the understanding and control of leukemia proliferation

1985 • 38 citations

Improving the management of patients with prostate cancer receiving long‐term androgen deprivation therapy

2012 • 34 citations

A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design

2012 • 29 citations

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

2010 • 28 citations

Safety and tolerability of intermittent androgen deprivation therapy: A literature review

2012 • 24 citations

Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial.

2012 • 23 citations

Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy

2012 • 20 citations

Gabapentin for the management of hot flashes in prostate cancer survivors: A longitudinal continuation study—NCCTG trial N00CB.

2010 • 19 citations

The Effect of Local Injections of Adrenalin on Epidermal Carcinogenesis in the Mouse

1952 • 7 citations